Inventor · disambiguated record
Heidi Greulich
Also filed as: GREULICH HEIDI
12 granted patents·11 pending applications·18 citations·filing 2014–2025
86Inventor score
Top patents by PatentIndex Score
23 records- 0194US11773070B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Oct 3, 2023·2 cites·9 claims
- 0290US12258323B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Mar 25, 2025·1 cites·15 claims
- 0390US11427553B2DihydrooxadiazinonesBAYER AG·Filed 2018·Granted Aug 30, 2022·4 cites·11 claims
- 0488US11142522B2Compounds, compositions and methods for cancer treatmentBROAD INST INC·Filed 2018·Granted Oct 12, 2021·4 cites·16 claims
- 0583US2024366620A1Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2024·Application pending·0 cites
- 0681US12325880B2Identification of PDE3 modulator responsive cancersBROAD INST INC·Filed 2019·Granted Jun 10, 2025·1 cites·13 claims
- 0781US9890127B2Compounds and compositions for the treatment of cancerBROAD INST INC·Filed 2014·Granted Feb 13, 2018·3 cites·12 claims
- 0879US10966986B2Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2017·Granted Apr 6, 2021·1 cites·8 claims
- 0974US12053476B2Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2021·Granted Aug 6, 2024·0 cites·6 claims
- 1074US11339157B14H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2018·Granted May 24, 2022·2 cites·19 claims
- 1174US2024182452A16-phenyl-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancerBAYER AG·Filed 2023·Application pending·0 cites
- 1271US2025136599A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2024·Application pending·0 cites
- 1367US2022071995A1Compositions and methods for cancer expressing pde3a or slfn12BROAD INST INC·Filed 2021·Application pending·0 cites
- 1465US12427153B21,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 1564US2023405015A1Substituted 3,6-dihydro-2h-1,3,4-oxadiazin-2-ones for the treatment of sarcomaBAYER AG·Filed 2023·Application pending·0 cites
- 1660US2025170136A11,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2025·Application pending·0 cites
- 1760US2023416249A1N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)ethyl]prop-2-enamide derivatives and similar compounds as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2023·Application pending·0 cites
- 1858US11207320B2Compositions and methods for cancer expressing PDE3A or SLFN12BROAD INST INC·Filed 2016·Granted Dec 28, 2021·0 cites·10 claims
- 1956US2023064983A13-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2022·Application pending·0 cites
- 2054US2022298157A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2020·Application pending·0 cites
- 2148US12403135B24H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2020·Granted Sep 2, 2025·0 cites·16 claims
- 2246US2024307362A14H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDSBAYER AG·Filed 2020·Application pending·0 cites
- 2345US2018244629A1Compounds And Compositions For The Treatment Of CancerBROAD INST INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heidi Greulich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →